Together, results from Fig. 7a–h mouse studies confirm our in vitro cell lines results showing that tretinoin can increase RCC sensitivity to sunitinib by targeting the TR4/lncTASR/AXL axis. The gene discussed is AXL; the disease is renal cell carcinoma.